182 related articles for article (PubMed ID: 22471284)
21. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
[TBL] [Abstract][Full Text] [Related]
24. Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
Yang HX; Zhang W; Zhao LD; Li Y; Zhang FC; Tang FL; He W; Zhang X
Arthritis Res Ther; 2009; 11(5):R153. PubMed ID: 19821980
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies.
Tsuda M; Torgerson TR; Selmi C; Gambineri E; Carneiro-Sampaio M; Mannurita SC; Leung PS; Norman GL; Gershwin ME
J Autoimmun; 2010 Nov; 35(3):265-8. PubMed ID: 20650610
[TBL] [Abstract][Full Text] [Related]
26. GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.
Hjorth M; Axelsson S; Rydén A; Faresjö M; Ludvigsson J; Casas R
Clin Immunol; 2011 Jan; 138(1):117-26. PubMed ID: 21044870
[TBL] [Abstract][Full Text] [Related]
27. Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus.
Ma L; Zhao P; Jiang Z; Shan Y; Jiang Y
Clin Exp Immunol; 2013 Dec; 174(3):345-55. PubMed ID: 23968502
[TBL] [Abstract][Full Text] [Related]
28. CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo.
Chachage M; Pollakis G; Kuffour EO; Haase K; Bauer A; Nadai Y; Podola L; Clowes P; Schiemann M; Henkel L; Hoffmann D; Joseph S; Bhuju S; Maboko L; Sarfo FS; Eberhardt K; Hoelscher M; Feldt T; Saathoff E; Geldmacher C
J Virol; 2016 Oct; 90(20):8954-67. PubMed ID: 27384654
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
30. The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins.
Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; Mol W; Weimar W; Baan CC
Clin Exp Immunol; 2010 Aug; 161(2):364-77. PubMed ID: 20528886
[TBL] [Abstract][Full Text] [Related]
31. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
32. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
33. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
34. Alterations of CD4(+) CD25(+) Foxp3(+) regulatory T cells in HIV-infected slow progressors of former blood donors in China.
Zhang Z; Jiang Y; Zhang M; Liu J; Sun G; Shi W; Wang Y; Shang H
Microbiol Immunol; 2010 Oct; 54(10):625-33. PubMed ID: 21118300
[TBL] [Abstract][Full Text] [Related]
35. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
Wang R; Huang K
Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children.
Freguja R; Gianesin K; Mosconi I; Zanchetta M; Carmona F; Rampon O; Giaquinto C; De Rossi A
Clin Exp Immunol; 2011 Jun; 164(3):373-80. PubMed ID: 21438872
[TBL] [Abstract][Full Text] [Related]
37. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.
Amarnath S; Dong L; Li J; Wu Y; Chen W
Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698
[TBL] [Abstract][Full Text] [Related]
38. Detection of CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood of patients with chronic autoimmune urticaria.
Sun RS; Sui JF; Chen XH; Ran XZ; Yang ZF; Guan WD; Yang T
Australas J Dermatol; 2011 Aug; 52(3):e15-8. PubMed ID: 21834806
[TBL] [Abstract][Full Text] [Related]
39. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.
Santner-Nanan B; Peek MJ; Khanam R; Richarts L; Zhu E; Fazekas de St Groth B; Nanan R
J Immunol; 2009 Dec; 183(11):7023-30. PubMed ID: 19915051
[TBL] [Abstract][Full Text] [Related]
40. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
